Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis

Author:

Goswami Rudra Prosad,Haldar Soumendra Nath,Chatterjee Moumita,Vij Pallavi,van der Kooi Anneke J.,Lim Johan,Raaphorst Joost,Bhadu Danveer,Gelardi Chiara,Danieli Maria Giovanna,Kumar Uma

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study;Lim;Rheumatology (Oxford),2020

2. Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review;Wang;Clin Rheumatol,2012

3. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial;Oddis;Arthritis Rheum,2013

4. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis;Dalakas;N Engl J Med,1993

5. Efficacy and safety of IVIg (Octagam 10%) in patients with active dermatomyositis. Results of a randomized, double-blind, placebo-controlled phase III trial (ProDERM study) [abstract];Aggarwal;Arthritis Rheumatol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3